Immune-Checkpoint Inhibitor (ICI) resumption after severe graft injury in a heart transplant recipient with nivolumab-sensitive metastatic melanoma and renal cell carcinoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of heart and lung transplantation 2022-12, Vol.41 (12), p.1860-1864
Hauptverfasser:	Tai, Warren, Doolittle, Gary C., Shah, Zubair, Atkinson, James B., Russell, Elaine, Genton, Randall E., Moslehi, Javid J., Porter, Charles B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma, Renal Cell - drug therapy Heart Transplantation - adverse effects Humans Immune Checkpoint Inhibitors Kidney Neoplasms - drug therapy Kidney Neoplasms - pathology Melanoma - drug therapy Melanoma - pathology Melanoma - secondary Nivolumab - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!